Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro

被引:52
作者
Ferreira, P
Oliveira, MJ
Beraldi, E
Mateus, AR
Nakajima, T
Gleave, M
Yokota, J
Carneiro, F
Huntsman, D
Seruca, R
Suriano, G [1 ]
机构
[1] Univ Porto, IPATIMUP, Inst Patol & Imunol Mol, P-4200 Oporto, Portugal
[2] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[3] Gunma Univ, Grad Sch Med, Dept Tumor Pathol, Gunma, Japan
[4] Natl Canc Ctr, Inst Res, Div Biol, Tokyo 104, Japan
[5] Hosp Sao Joao, Fac Med, Oporto, Portugal
[6] British Columbia Canc Agcy, Dept Pathol, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 4E6, Canada
[7] British Columbia Canc Agcy, Vancouver Gen Hosp, Prostate Ctr, Dept Pathol, Vancouver, BC V5Z 4E6, Canada
[8] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
E-cadherin; germline mutations; HDGC; apoptosis; bcl-2;
D O I
10.1016/j.yexcr.2005.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Experimental evidence supports a role for E-cadherin in suppressing invasion, metastasis, and proliferation. Germline mutations of the E-cadherin represent the genetic cause of hereditary diffuse gastric cancer (HDGC). In this type of tumor, isolated cancer cells permeate the basal membrane and paradoxically survive in the gastric wall in the absence of contact with neighbor epithelial cells or with the extracellular matrix. This suggests that upon E-cadherin deregulation, cells acquired resistance to apoptosis. To test this hypothesis, CHO cells stably expressing either wild-type E-cadherin or the HDGC-related germline mutations T340A and V832M were seeded either on a thin layer of collagen type I or on plastic and then subjected to the apoptotic agent taxol. We found that in vitro functional E-cadherin renders cells more sensitive to the effect of taxol. Our results also indicate that this effect is associated to decreased level of the antiapoptotic bcl-2 protein. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 22 条
[1]  
BECKER KF, 1994, CANCER RES, V54, P3845
[2]   Microtubule-targeted anticancer agents and apoptosis [J].
Bhalla, KN .
ONCOGENE, 2003, 22 (56) :9075-9086
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening [J].
Carneiro, F ;
Huntsman, DG ;
Smyrk, TC ;
Owen, DA ;
Seruca, R ;
Pharoah, P ;
Caldas, C ;
Sobrinho-Simoes, M .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :681-687
[5]   Interactions between growth factor receptors and adhesion molecules: breaking the rules [J].
Comoglio, PM ;
Boccaccio, C ;
Trusolino, L .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (05) :565-571
[6]   Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma [J].
Fricke, E ;
Keller, G ;
Becker, I ;
Rosivatz, E ;
Schott, C ;
Plaschke, S ;
Rudelius, M ;
Hermannstädter, C ;
Busch, R ;
Höfler, H ;
Becker, KF ;
Luber, B .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) :60-65
[7]   Integrins and anoikis [J].
Frisch, SM ;
Ruoslahti, E .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :701-706
[8]  
Gayther SA, 1998, CANCER RES, V58, P4086
[9]   E-cadherin germline mutations in familial gastric cancer [J].
Guilford, P ;
Hopkins, J ;
Harraway, J ;
McLeod, M ;
McLeod, N ;
Harawira, P ;
Taite, H ;
Scoular, R ;
Miller, A ;
Reeve, AE .
NATURE, 1998, 392 (6674) :402-405
[10]   Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. [J].
Huntsman, DG ;
Carneiro, F ;
Lewis, FR ;
MacLeod, PM ;
Hayashi, A ;
Monaghan, KG ;
Maung, R ;
Seruca, R ;
Jackson, CE ;
Caldas, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1904-1909